Home > Node

EGM - 9 January 2015

We would hereby like to notify that the Extraordinary General Meeting of Shareholders of Sopharma AD held on January 9, 2015 in Sofia took a decision for trnasformation of Sopharma AD throught the merger of Bulgarian Rose – Sevtopolis AD based in the city of Kazanlak, UIC 123007916. As a result the whole property of Bulgarian Rose – Sevtopolis AD will be transferred to Sopharma AD with the full rights.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 8 January 2015 up to and including 14 January 2015 the Company bought 2 677 own shares representing 0.002% of the share capital of the Company, to the total value of 9 957.10 BGN on the Bulgarian Stock Exchange, the average price per share was 3.72 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 120 127, representing 3.88% of the share capital of the Company.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 15 January 2015 up to and including 21 January 2015 the Company bought 1 000 own shares representing 0.00076% of the share capital of the Company, to the total value of 3 720.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.72 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 121 127, representing 3.88% of the share capital of the Company.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 10 February 2015 up to and including 13 February 2015 the Company bought 10 500 own shares representing 0.0080% of the share capital of the Company, at a total value of 37 792 BGN on the Bulgarian Stock Exchange, the average price per share was 3.599 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 136 521, representing 3.89% of the share capital of the Company.

English

Sales revenues for January 2015

Sopharma AD notifies that for January 2015 the Company recorded a decrease of sales revenues of 43% compared to the same month of 2014, including 11% increase of domestic sales and 61% decrease of export sales. 

The volatility of the RUB caused us to undertake actions to adjust the prices for our main export market - Russia, which prevented us from exporting during the period. Our forecast is that this slow down in the beginning of the year will be compensated already in the first quarter.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 10 February 2015 up to and including 13 February 2015 the Company bought 10 500 own shares representing 0.0080% of the share capital of the Company, at a total value of 37 792 BGN on the Bulgarian Stock Exchange, the average price per share was 3.599 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 136 521, representing 3.89% of the share capital of the Company.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 12 February 2015 up to and including 18 February 2015 the Company bought 7 150 own shares representing 0.0054% of the share capital of the Company, at a total value of 25 608.50 BGN on the Bulgarian Stock Exchange, the average price per share was 3.58 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 143 671, representing 3.90% of the share capital of the Company.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 19 February 2015 up to and including 25 February 2015 the Company bought 2 385 own shares representing 0.0018% of the share capital of the Company, at a total value of 8 195.40 BGN on the Bulgarian Stock Exchange, the average price per share was 3.44 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 146 056, representing 3.90% of the share capital of the Company.

English

Registration of the transformation through merger of Bulgarian Rose – Sevtopolis AD in Sopharma AD with Commercial Register

The Board of Directors hereby notifies that the transformation through merger of Bulgarian Rose – Sevtopolis AD in Sopharma AD has been registered with the Commercial Register with number 20150226134200. 

The registered capital of Sopharma AD is 134 797 899 BGN.Sopharma AD is now undertaking all necessary actions for registration of the new issuance of 2 797 899 shares, with nominal value of 1.00 BGN with the Central Depository AD.

English

Information about treasury shares

SOPHARMA AD hereby informs that from 26 February 2015 up to and including 4 March 2015 the Company bought 1 000 own shares representing 0.00076% of the share capital of the Company, at a total value of 3 280.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.28 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 147 056, representing 3.90% of the share capital of the Company.

English

Pages